BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 28043662)

  • 21. A novel risk assessment model of contrast-induced nephropathy after percutaneous coronary intervention in patients with diabetes.
    Yao ZF; Shen H; Tang MN; Yan Y; Ge JB
    Basic Clin Pharmacol Toxicol; 2021 Feb; 128(2):305-314. PubMed ID: 32991776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined impact of chronic kidney disease and contrast-induced nephropathy on long-term outcomes in patients with ST-segment elevation acute myocardial infarction who undergo primary percutaneous coronary intervention.
    Nakahashi H; Kosuge M; Sakamaki K; Kiyokuni M; Ebina T; Hibi K; Tsukahara K; Iwahashi N; Kuji S; Oba MS; Umemura S; Kimura K
    Heart Vessels; 2017 Jan; 32(1):22-29. PubMed ID: 27106917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-Terminal Fragment of Pro B-type Natriuretic Peptide as a Marker of Contrast-Induced Nephropathy After Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction.
    Goussot S; Mousson C; Guenancia C; Stamboul K; Brunel P; Brunet D; Touzery C; Cottin Y; Zeller M
    Am J Cardiol; 2015 Sep; 116(6):865-71. PubMed ID: 26183794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictive Value of CHA2DS2-VASC Score for Contrast-Induced Nephropathy After Percutaneous Coronary Intervention for Acute Coronary Syndrome.
    Kurtul A; Yarlioglues M; Duran M
    Am J Cardiol; 2017 Mar; 119(6):819-825. PubMed ID: 28040187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of contrast-induced nephropathy in patients undergoing complex percutaneous coronary intervention.
    Azzalini L; Poletti E; Lombardo F; Laricchia A; Beneduce A; Moscardelli S; Bellini B; Maccagni D; Cappelletti A; Ancona MB; Carlino M; Chieffo A; Colombo A; Montorfano M
    Int J Cardiol; 2019 Sep; 290():59-63. PubMed ID: 31005417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A New Preprocedure Risk Score for Predicting Contrast-Induced Acute Kidney Injury.
    Duan C; Cao Y; Liu Y; Zhou L; Ping K; Tan MT; Tan N; Chen J; Chen P
    Can J Cardiol; 2017 Jun; 33(6):714-723. PubMed ID: 28392272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CHA2DS2-VASc score as a novel predictor for contrast-induced nephropathy after percutaneous coronary intervention in acute coronary syndrome.
    Chaudhary AK; Pathak V; Kunal S; Shukla S; Pathak P
    Indian Heart J; 2019; 71(4):303-308. PubMed ID: 31779857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contrast induced acute kidney injury in acute coronary syndrome patients: A single centre experience.
    Farhan S; Vogel B; Tentzeris I; Jarai R; Freynhofer MK; Smetana P; Egger F; Kautzky-Willer A; Huber K
    Eur Heart J Acute Cardiovasc Care; 2016 Feb; 5(1):55-61. PubMed ID: 25722456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation.
    Mehran R; Aymong ED; Nikolsky E; Lasic Z; Iakovou I; Fahy M; Mintz GS; Lansky AJ; Moses JW; Stone GW; Leon MB; Dangas G
    J Am Coll Cardiol; 2004 Oct; 44(7):1393-9. PubMed ID: 15464318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of the blood urea nitrogen-to-left ventricular ejection fraction ratio with contrast-induced nephropathy in patients with acute coronary syndrome who underwent percutaneous coronary intervention.
    Kiris T; Avci E; Celik A
    Int Urol Nephrol; 2019 Mar; 51(3):475-481. PubMed ID: 30604231
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of radial versus femoral access with contrast-induced acute kidney injury in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction.
    Kolte D; Spence N; Puthawala M; Hyder O; Tuohy CP; Davidson CB; Sheldon MW; Laskey WK; Abbott JD
    Cardiovasc Revasc Med; 2016 Dec; 17(8):546-551. PubMed ID: 27566903
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Risk factors and scoring system in the prediction of contrast induced nephropathy in patients undergoing percutaneous coronary intervention].
    Fu NK; Yang SC; Chen YL; Xu J; Li Q; Li XM; Liu YY; Liu XG; Cong HL
    Zhonghua Yi Xue Za Zhi; 2012 Feb; 92(8):551-4. PubMed ID: 22490160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Usefulness of C-Reactive Protein as a Predictor of Contrast-Induced Nephropathy After Percutaneous Coronary Interventions in Patients With Acute Myocardial Infarction and Presentation of a New Risk Score (Athens CIN Score).
    Lazaros G; Zografos T; Oikonomou E; Siasos G; Georgiopoulos G; Vavuranakis M; Antonopoulos A; Kalogeras K; Tsalamandris S; Tousoulis D
    Am J Cardiol; 2016 Nov; 118(9):1329-1333. PubMed ID: 27745963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel tool for reliable and accurate prediction of renal complications in patients undergoing percutaneous coronary intervention.
    Gurm HS; Seth M; Kooiman J; Share D
    J Am Coll Cardiol; 2013 Jun; 61(22):2242-8. PubMed ID: 23721921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk prediction of contrast-induced nephropathy by ACEF score in patients undergoing coronary catheterization.
    Capodanno D; Ministeri M; Dipasqua F; Dalessandro V; Cumbo S; Gargiulo G; Tamburino C
    J Cardiovasc Med (Hagerstown); 2016 Jul; 17(7):524-9. PubMed ID: 25304032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A prediction model of contrast-associated acute kidney injury in patients with hypoalbuminemia undergoing coronary angiography.
    Liu L; Liu J; Lei L; Wang B; Sun G; Guo Z; He Y; Song F; Lun Z; Liu B; Chen G; Chen S; Yang Y; Liu Y; Chen J
    BMC Cardiovasc Disord; 2020 Aug; 20(1):399. PubMed ID: 32867690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simple pre-procedure risk stratification tool for contrast-induced nephropathy.
    Ni Z; Liang Y; Xie N; Liu J; Sun G; Chen S; Ye J; He Y; Guo W; Tan N; Chen J; Liu Y; Chen Z; Wang S
    J Thorac Dis; 2019 Apr; 11(4):1597-1610. PubMed ID: 31179104
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictive value of ATRIA risk score for contrast-induced nephropathy after percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Aksoy F; Bagcı A
    Rev Assoc Med Bras (1992); 2019 Nov; 65(11):1384-1390. PubMed ID: 31800901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ADVANCIS Score Predicts Acute Kidney Injury After Percutaneous Coronary Intervention for Acute Coronary Syndrome.
    Fan PC; Chen TH; Lee CC; Tsai TY; Chen YC; Chang CH
    Int J Med Sci; 2018; 15(5):528-535. PubMed ID: 29559842
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-sensitivity C-reactive protein predicts contrast-induced nephropathy after primary percutaneous coronary intervention.
    Liu Y; Tan N; Zhou YL; Chen YY; Chen JY; Chen J; Luo JF
    J Nephrol; 2012; 25(3):332-40. PubMed ID: 21928234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.